2 results
Approved WMOCompleted
This study is designed to investigate the limiting effect on infarct size of high dose intravenous adenosine during primary angioplasty
Approved WMORecruiting
Objective: To compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, withrespect to progression-free survival (PFS) per RECIST 1.1 as assessed by the investigator.